NASDAQ
BiondVax Pharmaceuticals Ltd. (BVXV) has a current ratio of 6.15x as of Monday, May 25, 2026. This represents a 61.89% increase compared to its 12-month average of 3.80x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.